Health
FinchFile verdict
RealMembership is $11.99 a year. Your stamp goes on the public tally. The desk verdict stays independent.
Get tomorrow's stamps
Free daily email. Come back without waiting on Google.
Claim parts
- Who
- The U.S. Food
- What
- approved
Evidence test
FinchFile doesn't ask you to trust us. It shows you the evidence. Real means this claim passed FinchFile's evidence test — not that we are an authority on truth.
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
Dose Check · Sep 24, 3:01 PM
Cite this stamp
Paste the link when you argue the claim. Other sites can embed the badge.
https://finchfile.com/story/ba857e19b9
Related stamps
More FinchFile checks in Health.
- DependsThere have been six hospitalizations related to E. coli illnesses linked to frozen blueberries, the Food and Drug Administration said.Depends
- RealFormer Hospital Registered Nurse Indicted, Charged with Prescription Drug FraudReal
- DependsWhy would a person pick a potential life partner without feeling the spark of sexual attraction? And can these relationships survive and …Depends
